PIK3CA and prostate carcinoma: To test this hypothesis, we chose as a model system prostate cancer because hyperactivation of the PI3K-AKT-mTOR pathway has been associated with disease progression from the primary to metastatic phase and carboxymethyl sensitive PP2A regulatory subunits regulates this pathway24,37,38.